+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Continuous Blood Glucose Monitoring Systems Market by Product (Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems), Component (CGM Monitor, CGM Transmitter, Glucose Sensor), Testing Site, Patient Care Setting, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896486
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Continuous Blood Glucose Monitoring Systems Market size was estimated at USD 4.50 billion in 2023, USD 4.86 billion in 2024, and is expected to grow at a CAGR of 8.14% to reach USD 7.79 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Continuous Blood Glucose Monitoring Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Continuous Blood Glucose Monitoring Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Continuous Blood Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, B. Braun Melsungen AG, Dexcom, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, GlySens Incorporated, Johnson & Johnson Services, Inc., LifeScan IP Holdings, LLC, Medtronic PLC, Novo Nordisk A/S, OrSense Ltd., PHC Holdings Corporation, Senseonics Holdings, Inc., and Tandem Diabetes Care, Inc.

Market Segmentation & Coverage

This research report categorizes the Continuous Blood Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Continuous Glucose Monitoring Systems
      • Receivers
      • Sensors
      • Transmitters
    • Self-Monitoring Blood Glucose Systems
      • Blood Glucose Meters
      • Lancets & Lancing Devices
      • Testing strips
  • Component
    • CGM Monitor
    • CGM Transmitter
    • Glucose Sensor
  • Testing Site
    • Alternate Site Testing
    • Fingertip Testing
  • Patient Care Setting
    • Hospital & Clinics
    • Self or Home Care
  • Application
    • Gestational Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Continuous Blood Glucose Monitoring Systems Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Continuous Blood Glucose Monitoring Systems Market?
  3. What are the technology trends and regulatory frameworks in the Continuous Blood Glucose Monitoring Systems Market?
  4. What is the market share of the leading vendors in the Continuous Blood Glucose Monitoring Systems Market?
  5. Which modes and strategic moves are suitable for entering the Continuous Blood Glucose Monitoring Systems Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Continuous Blood Glucose Monitoring Systems Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
5.1.1.2. Benefits associated with continuous blood glucose monitoring systems over Point-of-Care glucometers
5.1.1.3. Increasing awareness through government initiatives for the product
5.1.2. Restraints
5.1.2.1. Accuracy and precision on measurement and cost associated with sensor lifetime
5.1.3. Opportunities
5.1.3.1. Growing adoption rate of continuous blood glucose monitoring systems in home healthcare
5.1.3.2. Potential undiagnosed patient population
5.1.4. Challenges
5.1.4.1. Instability of patterns and reproducibility to results
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Continuous Blood Glucose Monitoring Systems Market, by Product
6.1. Introduction
6.2. Continuous Glucose Monitoring Systems
6.3.1. Receivers
6.3.2. Sensors
6.3.3. Transmitters
6.3. Self-Monitoring Blood Glucose Systems
6.4.1. Blood Glucose Meters
6.4.2. Lancets & Lancing Devices
6.4.3. Testing strips
7. Continuous Blood Glucose Monitoring Systems Market, by Component
7.1. Introduction
7.2. CGM Monitor
7.3. CGM Transmitter
7.4. Glucose Sensor
8. Continuous Blood Glucose Monitoring Systems Market, by Testing Site
8.1. Introduction
8.2. Alternate Site Testing
8.3. Fingertip Testing
9. Continuous Blood Glucose Monitoring Systems Market, by Patient Care Setting
9.1. Introduction
9.2. Hospital & Clinics
9.3. Self or Home Care
10. Continuous Blood Glucose Monitoring Systems Market, by Application
10.1. Introduction
10.2. Gestational Diabetes
10.3. Type 1 Diabetes
10.4. Type 2 Diabetes
11. Americas Continuous Blood Glucose Monitoring Systems Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Continuous Blood Glucose Monitoring Systems Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. A. Menarini Diagnostics s.r.l.
15.1.2. Abbott Laboratories
15.1.3. B. Braun Melsungen AG
15.1.4. Dexcom, Inc.
15.1.5. Eli Lilly and Company
15.1.6. F. Hoffmann-La Roche AG
15.1.7. GlySens Incorporated
15.1.8. Johnson & Johnson Services, Inc.
15.1.9. LifeScan IP Holdings, LLC
15.1.10. Medtronic PLC
15.1.11. Novo Nordisk A/S
15.1.12. OrSense Ltd.
15.1.13. PHC Holdings Corporation
15.1.14. Senseonics Holdings, Inc.
15.1.15. Tandem Diabetes Care, Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
FIGURE 3. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
FIGURE 7. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 10. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
FIGURE 12. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2023 VS 2030 (%)
FIGURE 14. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 8. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 13. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LANCETS & LANCING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 17. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CGM TRANSMITTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GLUCOSE SENSOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 21. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ALTERNATE SITE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY FINGERTIP TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 24. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF OR HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 55. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 57. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 58. CANADA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 93. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 94. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 95. CHINA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 98. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 99. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 101. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 102. INDIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 112. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 116. JAPAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 154. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 155. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 156. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 158. THAILAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 180. DENMARK CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 185. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 187. EGYPT CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 190. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 197. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 198. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 199. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 201. FRANCE CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 204. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 218. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 219. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 220. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 221. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 222. ITALY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 239. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 248. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 249. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 250. POLAND CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 253. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 254. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 255. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 256. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 257. QATAR CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT CARE SETTING, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PR

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • A. Menarini Diagnostics s.r.l.
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlySens Incorporated
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holdings, LLC
  • Medtronic PLC
  • Novo Nordisk A/S
  • OrSense Ltd.
  • PHC Holdings Corporation
  • Senseonics Holdings, Inc.
  • Tandem Diabetes Care, Inc.

Methodology

Loading
LOADING...

Table Information